Abstract:Objectives Adipokines have been shown to play an important role in coronary heart disease (CAD). Anti-inflammatory adipokines like adiponectin and omentin protect the vessels from plaque formation. On the other hand, release of pro-inflammatory adipokines like leptin will accelerate plaque formation and lead to coronary atherosclerosis. However, the impact of these adipokines on coronary microvascular dysfunction is not clear. Coronary flow reserve (CFR) is a marker of microvascular dysfunction. CFR < 3 suggests involvement of microvascular dysfunction. We sought to assess whether adipokines which included leptin, adiponectin and omentin, could be associated with CFR. Methods We enrolled 61 nondiabetic patients who underwent computed tomography angiography or invasive coronary angiography and had no obstructive coronary artery disease (coronary stenosis < 50%). Data about classical risk factors, such as gender, age were obtained. CFR was measured by transthoracic doppler echocardiography (TTDE). Serum leptin, adiponectin and omentin were measured by enzyme-linked immunosorbent assay. Results 61 patients (23 men and 38 women) with a mean age of 59 ± 10 years were enrolled. The mean CFR is 2.98 ± 0.67. 34 patients (56%) had reduced CFR (CFR < 3, mean 2.52 ± 0.32) suggestive of microvascular dysfunction and 27 patients (44%) had normal CFR (CFR ≥ 3, mean 3.56 ± 0.52). Classical risk factors of atherosclerosis such as body mass index (BMI), blood cholesterol, blood glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and family history of coronary heart disease showed no difference between two groups. Serum omentin was significantly decreased in patients with microvascular dysfunction as compared with those without (198.77 ± 23.83 ng/ml vs. 213.50 ± 17.62 ng/ml, P = 0.010). And the same result was revealed in men and women respectively (men 186.98 ± 25.40 ng/ml vs. 212.29 ± 18.46 ng/ml, P = 0.026; women 199.33 ± 21.92 ng/ml vs. 217.76 ± 15.10 ng/ml, P = 0.021). Whether in men or women, serum leptin and adiponectin showed no difference between two groups. Serum omentin was positively related to CFR (r = 0.361, P = 0.006), and it showed the same result in men and women respectively (men r = 0.353, P = 0.007; women r = 0.458, P = 0.006). In addition, baseline systolic blood pressure is also related to CFR (r = -0.264, P = 0.042). There were no marked correlation between serum leptin, adiponectin and CFR. On logistic regression analysis, serum omentin was the independent predictor of coronary microvascular dysfunction (OR = 0.62, CI 95%: 0.40-0.96). Conclusions Serum omentin was decreased in patients with coronary microvascular dysfunction. It is the independent predictor of coronary microvascular dysfunction.There are no marked correlation between serum leptin, adiponectin and CFR.

Expression and its clinical significance of plasma omentin-1 in patients with coronary heart disease and central obesity

Positive Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population.

Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults

Serum Omentin Level and Related Factors in Obese and Type 2 Diabetic Patients

The Association Between Chinese Patients' Elevated Omentin-1 Levels, Their Clinicopathological Features, and the Risk of Colorectal Cancer.

[Expression of Omentin in Adipose Tissues in Obese and Type 2 Diabetic Patients].

Serum Omentin-1 Levels in Overweight and Obese People

Association between serum omentin-1 level and childhood non-alcoholic fatty liver disease

Central Fat Accumulation Associated with Metabolic Risks Beyond Total Fat in Normal BMI Chinese Adults.

Impact of Serum Omentin-1 Levels on Functional Prognosis in Nondiabetic Patients with Ischemic Stroke.

Changes and clinical significance of plasma brain-gut peptide in obese patients with glycometabolism abnormality

Study of Relationships Between Intra-Abdominal Obesity and High Sensitive C-reactive Protein,tissue Inhibitor of Metalloproteinase-1 in Patients with Coronary Heart Disease

Plasma Heme Oxygenase-1 Concentration in Relation to Impaired Glucose Regulation in a Non-Diabetic Chinese Population

GW24-e3709 Relation Between Adipokines and Coronary Flow Reserve in Patients with Chest Pain and Angiographically Normal Arteries

Omentin-1: a newly discovered warrior against metabolic related diseases

Changes of plasma Obestatin and Ghrelin in Diabetes mellitus.

Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies

The adipocytokine omentin and its relationship with atherosclerosis

Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study

Association between heme oxygenase-1 and hyperlipidemia in pre-diabetic patients: a cross-sectional study

Clinical relevance of serum omentin‐1 levels as a biomarker of prognosis in patients with acute cerebral infarction